Overview
Drug-induced acute pancreatitis occurs as a hypersensitivity or direct toxic effect of certain medications, often within therapeutic dose ranges 1.Diagnosis
Clinical Presentation: Severe abdominal pain, elevated serum amylase and lipase levels 1.
Imaging: Abdominal CT or MRI may show characteristic findings of pancreatitis 1.
Elimination of Other Causes: Rule out gallstones, alcohol use, and other etiologies 1.
Drug History: Detailed review to identify potential offending agents 1.Management
Discontinue Offending Agent: Immediate cessation of the suspected drug 1.
Supportive Care: Fluid resuscitation, pain management, and monitoring for complications 1.
Nutritional Support: Initiate enteral feeding if oral intake is not possible 1.
Monitoring: Frequent lab monitoring (amylase, lipase, electrolytes) and clinical assessment 1.Special Populations
No Specific Data Provided: Abstracts do not provide detailed information on management in pregnancy, pediatrics, elderly, or specific comorbidities 12.Key Recommendations
Identify and Discontinue the Offending Drug: Promptly discontinue any drug suspected of causing acute pancreatitis within therapeutic dose ranges (Evidence: Moderate) 1.
Supportive Measures: Implement supportive care including fluid resuscitation and pain management (Evidence: Moderate) 1.
Monitor Closely: Regularly monitor laboratory parameters and clinical status to manage complications (Evidence: Moderate) 1.References
1 Calderón-Ospina C, Bustamante-Rojas C. The DoTS classification is a useful way to classify adverse drug reactions: a preliminary study in hospitalized patients. The International journal of pharmacy practice 2010. link
2 Prusak E, Kustrzeba-Wójcicka I, Wilusz T, Szewczuk A. Effect of some chemical modifications of basic pancreatic trypsin inhibitor (BPTI) on its reaction with specific antibody. Archivum immunologiae et therapiae experimentalis 1984. link